Comparison of Early and Late Changes in Immunoglobulins and Acute Phase Reactants after Laparoscopic Adjustable Gastric Banding in Patients with Morbid Obesity
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
There are differences in the levels of inflammation mediators, lipids, and formed elements of the blood in morbidly obese patients compared with individuals of normal weight. In the current study, the change in these parameters was determined in patients who achieved weight loss by undergoing laparoscopic adjustable gastric banding (LAGB) by comparing preoperative, and early (3 months) and late (12 months) postoperative values.
The body mass index (BMI), weight, blood pressure, and waist circumference of 72 patients treated by LAGB procedures between September 2006 and February 2009 were measured and recorded. Pre- and postoperative 3- and 12-month C-reactive protein (CRP), immunoglobulin (Ig) G, IgA, IgM, fibrinogen (Fbg), complement components C3 and C4, total cholesterol, triglycerides, low-density lipoprotein-C and high-density lipoprotein-C levels, and leukocyte, neutrophil, lymphocyte, and platelet counts were also measured. Results were presented as mean ± SD. The preoperative values were compared with the 3- and 12-month values. A p value < 0.05 was considered statistically significant.
BMI, weight, blood pressure, and waist circumference measurements were reduced at 3 and 12 months postoperatively compared with preoperative values (p < 0.05). Among the inflammatory mediators, IgG, IgM, and Fbg were reduced to near-normal values, beginning in the early postoperative period (p < 0.05). There was no significant reduction parallel to weight loss with respect to CRP, C3, C4, and IgA values at 3 months postoperatively (p > 0.05). However, the 12-month values of these parameters were significantly reduced (p < 0.05).
Morbid obesity leads to significant changes in the levels of inflammation mediators. While there is a significant reduction in some of these mediators accompanying slight weight loss in the early period following an LAGB procedure, significant changes occur in other mediators in the late period when there is a larger amount of weight loss.
- Lew EA, Garfinkel L. Variations in mortality by weight among 750, 000 men and women. J Chronic Dis. 1979;32:563–76. CrossRef
- National Institutes of Health. National Institutes of Health Consensus Development panel on the Health Implications of Obesity. National Institutes of Health Consensus development conference statement. Ann Intern Med. 1985;103:1072–7.
- Krishnan EC, Trost L, Aarons S, et al. Study of function and maturation of monocytes in morbidly obese individuals. J Surg Res. 1982;33:89–97. CrossRef
- Cottam DR, Mattar SG, Barinas-Mitchell E, et al. The chronic inflammatory hypothesis for the morbidity associated with morbid obesity: implications and effects of weight loss. Obes Surg. 2004;14:589–600. CrossRef
- Brownell KD, Greenwood MR, Stellar E, et al. The effects of repeated cycles of weight loss and regain in rats. Physiol Behav. 1986;38:459–64. CrossRef
- Holt RI. International Diabetes Federation re-defines the metabolic syndrome. Diabetes Obes Metab. 2005;7:618–20. CrossRef
- Visser M, Bouter LM, McQuillan GM, et al. Elevated C-reactive protein levels in overweight and obese adults. JAMA. 1999;282:2131–5. CrossRef
- Ford ES. Body mass index, diabetes, and C-reactive protein among U.S. adults. Diabetes Care. 1999;22:1971–7. CrossRef
- Schuchert VD, Billiar TR. Inflammation. In: Greenfield LJ, editor. Surgery Scientific principals and practice. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2001. p. 134–78.
- Mohamed-Ali V, Pinkney JH, Coppack SW. Adipose tissue as an endocrine and paracrine organ. Int J Obes Relat Metab Disord. 1998;22:1145–58. CrossRef
- Weinhold B, Rüther U. Interleukin-6-dependent and -independent regulation of the human C-reactive protein gene. Biochem J. 1997;327:425–9.
- Van Harmelen V, Ariapart P, Hoffstedt J, et al. Increased adipose angiotensinogen gene expression in human obesity. Obes Res. 2000;8:337–41. CrossRef
- Korenkov M, Shah S, Sauerland S, et al. Impact of laparoscopic adjustable gastric banding on obesity co-morbidities in the medium- and long-term. Obes Surg. 2007;17:679–83. CrossRef
- Fanari P, Somazzi R, Nasrawi F, et al. Haemorheological changes in obese adolescents after short-term diet. Int J Obes Relat Metab Disord. 1993;17:487–94.
- Freedman DS, Joesoef MR, Barboriak JJ, et al. Correlates of leukocyte counts in men. Ann Epidemiol. 1996;6:74–82. CrossRef
- Paolo F, Somazzi R, Nasrawi F, et al. Haemorheological changes in obese adolescents after short-term diet. Int J Obes. 1993;17:487–94.
- Marks HH. Influence of obesity on morbidity and mortality. Bull NY Acad Med. 1960;36:296–312.
- Tracey VV, De NC, Harper JR. Obesity and respiratory infection in infants and young children. Br Med J. 1971;1:16–8. CrossRef
- Hanusch-Enserer U, Cauza E, Spak M, et al. Acute-phase response and immunological markers in morbid obese patients and patients following adjustable gastric banding. Int J Obes Relat Metab Disord. 2003;27:355–61. CrossRef
- Laimer M, Ebenbichler CF, Kaser S, et al. Markers of chronic inflammation and obesity: a prospective study on the reversibility of this association in middle-aged women undergoing weight loss by surgical intervention. Int J Obes Relat Metab Disord. 2002;26:659–62. CrossRef
- Vázquez LA, Pazos F, Berrazueta JR, et al. Effects of changes in body weight and insulin resistance on inflammation and endothelial function in morbid obesity after bariatric surgery. J Clin Endocrinol Metab. 2005;90:316–22. CrossRef
- Kopp HP, Kopp CW, Festa A, et al. Impact of weight loss on inflammatory proteins and their association with the insulin resistance syndrome in morbidly obese patients. Arterioscler Thromb Vasc Biol. 2003;23:1042–7. CrossRef
- Marckmann P, Toubro S, Astrup A. Sustained improvement in blood lipids, coagulation, and fibrinolysis after major weight loss in obese subjects. Eur J Clin Nutr. 1998;52:329–33. CrossRef
- Primrose JN, Davies JA, Prentice CR, et al. Reduction in factor VII, fibrinogen and plasminogen activator inhibitor-1 activity after surgical treatment of morbid obesity. Thromb Haemost. 1992;68:396–9.
- Rowan BO, Kuhl DA, Lee MD, et al. Anti-Xa levels in bariatric surgery patients receiving prophylactic enoxaparin. Obes Surg. 2008;18:162–6. CrossRef
- Ditschuneit HH, Flechtner-Mors M, Adler G. Fibrinogen in obesity before and after weight reduction. Obes Res. 1995;3:43–8.
- Haffner SM, Mykkänen L, Festa A, et al. Insulin-resistant prediabetic subjects have more atherogenic risk factors than insulin-sensitive prediabetic subjects: implications for preventing coronary heart disease during the prediabetic state. Circulation. 2000;101:975–80.
- Stallone DD, Stunkard AJ, Zweiman B, et al. Decline in delayed-type hypersensitivity response in obese women following weight reduction. Clin Diagn Lab Immunol. 1994;1:202–5.
- Nieman DC, Nehlsen-Cannarella SI, Henson DA, et al. Immune response to obesity and moderate weight loss. Int J Obes Relat Metab Disord. 1996;20:353–60.
- Solá E, Jover A, López-Ruiz A, et al. Parameters of inflammation in morbid obesity: lack of effect of moderate weight loss. Obes Surg. 2009;19:571–6. CrossRef
- Vilarrasa N, Vendrell J, Sánchez-Santos R, et al. Effect of weight loss induced by gastric bypass on proinflammatory interleukin-18, soluble tumour necrosis factor-alpha receptors, C-reactive protein and adiponectin in morbidly obese patients. Clin Endocrinol (Oxf). 2007;67:679–86. CrossRef
- Whitson BA, D'Cunha J, Hoang CD, et al. Minimally invasive versus open Roux-en-Y gastric bypass: effect on immune effector cells. Surg Obes Relat Dis. 2009;5:181–93. CrossRef
- Comparison of Early and Late Changes in Immunoglobulins and Acute Phase Reactants after Laparoscopic Adjustable Gastric Banding in Patients with Morbid Obesity
Volume 20, Issue 5 , pp 610-615
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Gastric banding
- Industry Sectors
- Author Affiliations
- 1. Department of General Surgery, Numune Teaching and Research Hospital, 06100, Ankara, Turkey
- 4. Numune Teaching and Education Hospital, Sıhhiye, Ankara, Turkey
- 5. Cukurambar mah, 42. Cadde Sancak Apartmanı, No: 11/7 06600 Cankaya, Ankara, Turkey
- 2. Department of Nutrition, Numune Teaching and Research Hospital, 06100, Ankara, Turkey
- 3. Department of Biostatistics, Faculty of Medicine, Hacettepe University, 06100, Ankara, Turkey